about
Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramificationsThe Role of Reactive Oxygen Species in Myelofibrosis and Related NeoplasmsCHK2 kinase promotes pre-mRNA splicing via phosphorylating CDK11(p110)The CHEK2 gene and inherited breast cancer susceptibilityCHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.Germline mutations in BRCA1, BRCA2, CHEK2 and TP53 in patients at high-risk for HBOC: characterizing a Northeast Brazilian PopulationRare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening studyGenome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactionsEndometrial cancer gene panels: clinical diagnostic vs research germline DNA testing.Extracolonic manifestations of lynch syndromeCHEK2 1100delC in patients with metachronous cancers of the breast and the colorectum.Linkage disequilibrium mapping of CHEK2: common variation and breast cancer risk.Genotyping panel for assessing response to cancer chemotherapy.Hereditary breast cancer: ever more pieces to the polygenic puzzle.Identification of a novel CHEK2 variant and assessment of its contribution to the risk of breast cancer in French Canadian women.Evolutionary analysis of the highly dynamic CHEK2 duplicon in anthropoidsThe Prevalence of Founder Mutations among Individuals from Families with Familial Pancreatic Cancer Syndrome.Current perspectives on CHEK2 mutations in breast cancer.The updated Swedish family-cancer database used to assess familial risks of prostate cancer during rapidly increasing incidence.Variants in the ATM-CHEK2-BRCA1 axis determine genetic predisposition and clinical presentation of papillary thyroid carcinoma.An association study between CHEK2 gene mutations and susceptibility to breast cancer.First evidence of a large CHEK2 duplication involved in cancer predisposition in an Italian family with hereditary breast cancer.Cancer driver mutations in protein kinase genesPanel-based testing for inherited colorectal cancer: a descriptive study of clinical testing performed by a US laboratory.Synchronous primary triple carcinoma of thyroid and kidney accompanied by solitary fibrous tumor of the kidney: a unique case report.Variant allele of CHEK2 is associated with a decreased risk of esophageal cancer lymph node metastasis in a Chinese population.A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma.Copy number alteration and uniparental disomy analysis categorizes Japanese papillary thyroid carcinomas into distinct groups.Identification and characterization of novel SNPs in CHEK2 in Ashkenazi Jewish men with prostate cancerA genome-wide scan of 10 000 gene-centric variants and colorectal cancer riskThe checkpointkinase 2 (CHK2) 1100delC germ line mutation is not associated with the development of squamous cell carcinoma of the head and neck (SCCHN).CHEK2 (∗) 1100delC Mutation and Risk of Prostate Cancer.Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations?Eurocan Platform meeting: European recommendations for biomarker-based chemoprevention trialsConstitutional CHEK2 mutations are infrequent in early-onset and familial breast/ovarian cancer patients from Pakistan.CHK2 kinase in the DNA damage response and beyondLow prevalence of CHEK2 gene mutations in multiethnic cohorts of breast cancer patients in Malaysia.The CHEK2 1100delC allelic variant is not present in familial and sporadic breast cancer cases from Moroccan population.Three Metachronous Cases of HER2-Positive Breast Cancer Accompanied with Thyroid Cancer.Fusion of the tumor-suppressor gene CHEK2 and the gene for the regulatory subunit B of protein phosphatase 2 PPP2R2A in childhood teratoma
P2860
Q24610838-B9A34C6D-E35E-4DDB-90DD-4AF3DA494A01Q26779929-4A99CDAF-F241-46FE-BA30-477A4CCBCC5EQ28118922-57913B09-B5AA-41BC-ACAB-FE92C8C99B1DQ28265315-7E7DD640-6BA4-4A4B-8A8A-508649B2CA28Q28387717-E12B22AC-CE7F-4192-9D4B-3BF449D8E47BQ28389268-2DC6BEFE-5ABC-4964-B0B0-22CBDCA3440CQ28743906-493594F5-4D68-42B4-AA65-C804F91E708CQ28943312-2333BA5F-511D-490A-B283-FF4455AB3807Q30234614-A21ED0DA-1FF8-4298-8A97-C5753FE194B1Q30453984-4420BA62-40D4-48DE-8A16-5BDC3ADFCA83Q33236605-8F0A8B77-6059-432A-AE8B-A6BE7160B95FQ33242074-CEB53537-4515-45A7-925C-A15F5CE9F3A1Q33343095-21242EF0-B58B-42AB-B51D-2863A4972BA4Q33356511-1610782C-1D0A-41CC-BAFF-97E840E928FBQ33360437-93857E2C-C9F6-47EE-98E7-5C3C5E705E72Q33373501-DE01FA0C-C8C7-476A-ABF4-AA4055FCB348Q33584095-DBA5DEC4-6353-4F8E-A388-E4B7D42F0BE0Q33712610-8DF2B68E-42C0-4235-B508-90121097B3F2Q33722592-87C3C04E-8037-4FDF-998D-2621B04DE91BQ33760096-8908874B-4C87-4B89-8E27-79C633B68500Q33849571-CB3E1972-7492-4D12-ABC1-5E94373697AEQ33882010-71EA25E4-AF2A-49CD-9799-47742167D767Q34002709-3A1A5A12-C331-4DB9-9321-3EB868761B61Q34022144-4811281F-41E1-4028-A703-C2CDAC2886BEQ34029238-02711951-A9B7-4E18-BEAA-5C6BAB4A95ECQ34112490-E85FCD13-D645-4EBE-A1F0-CB034E96DF68Q34162606-2D5EB3EA-9D13-45D6-904A-70ED8197F1CFQ34257114-4E120F84-61CD-4DB1-88B9-A74A70CE7F67Q34263742-BA97A0B9-D0F6-4063-8BCF-B53812F425FCQ34327333-23973208-C8BD-41A7-B298-159691A67225Q34478300-09EB786F-4138-42AB-BD20-909258CE8E0BQ34560743-246C6A8C-0A50-4266-A2B0-72E94A49AB9AQ34572576-02021691-C843-4757-A51F-B90C6931E4D9Q34680673-DE2D823C-FE24-40F0-97B0-0DB47F144FB7Q34786007-8BAE5230-6274-4998-8474-365C2C237652Q34977480-75FCF811-567E-4CAA-8F57-AB2C5C8BA9FDQ35023623-0AE78610-F1ED-4027-9E27-0E64C4D2E4BDQ35059075-40B59945-62B0-4086-B8E0-D26CB1812E8AQ35066950-AF07C5C0-BAF9-47B1-9EBA-20D774E81656Q35070054-AE03250E-5D41-41CB-B664-16C5B5B4FDCF
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
CHEK2 is a multiorgan cancer susceptibility gene.
@ast
CHEK2 is a multiorgan cancer susceptibility gene.
@en
CHEK2 is a multiorgan cancer susceptibility gene.
@nl
type
label
CHEK2 is a multiorgan cancer susceptibility gene.
@ast
CHEK2 is a multiorgan cancer susceptibility gene.
@en
CHEK2 is a multiorgan cancer susceptibility gene.
@nl
prefLabel
CHEK2 is a multiorgan cancer susceptibility gene.
@ast
CHEK2 is a multiorgan cancer susceptibility gene.
@en
CHEK2 is a multiorgan cancer susceptibility gene.
@nl
P2093
P2860
P50
P356
P1476
CHEK2 is a multiorgan cancer susceptibility gene.
@en
P2093
Castaneda J
Grabowska E
Gronwald J
Huzarski T
Matyjasik J
P2860
P304
P356
10.1086/426403
P407
P577
2004-10-18T00:00:00Z